1. Home
  2. MMI vs FTRE Comparison

MMI vs FTRE Comparison

Compare MMI & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMI
  • FTRE
  • Stock Information
  • Founded
  • MMI 1971
  • FTRE 1996
  • Country
  • MMI United States
  • FTRE United States
  • Employees
  • MMI N/A
  • FTRE N/A
  • Industry
  • MMI Real Estate
  • FTRE Medical Specialities
  • Sector
  • MMI Finance
  • FTRE Health Care
  • Exchange
  • MMI Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • MMI 1.5B
  • FTRE 1.4B
  • IPO Year
  • MMI 2013
  • FTRE N/A
  • Fundamental
  • Price
  • MMI $37.50
  • FTRE $14.88
  • Analyst Decision
  • MMI Sell
  • FTRE Hold
  • Analyst Count
  • MMI 1
  • FTRE 11
  • Target Price
  • MMI $30.00
  • FTRE $23.30
  • AVG Volume (30 Days)
  • MMI 102.8K
  • FTRE 1.2M
  • Earning Date
  • MMI 02-14-2025
  • FTRE 03-03-2025
  • Dividend Yield
  • MMI 1.32%
  • FTRE N/A
  • EPS Growth
  • MMI N/A
  • FTRE N/A
  • EPS
  • MMI N/A
  • FTRE N/A
  • Revenue
  • MMI $696,060,000.00
  • FTRE $2,975,600,000.00
  • Revenue This Year
  • MMI $19.64
  • FTRE N/A
  • Revenue Next Year
  • MMI $22.25
  • FTRE $1.02
  • P/E Ratio
  • MMI N/A
  • FTRE N/A
  • Revenue Growth
  • MMI 7.76
  • FTRE 2.80
  • 52 Week Low
  • MMI $29.93
  • FTRE $14.27
  • 52 Week High
  • MMI $42.80
  • FTRE $41.02
  • Technical
  • Relative Strength Index (RSI)
  • MMI 48.38
  • FTRE 34.60
  • Support Level
  • MMI $37.27
  • FTRE $14.88
  • Resistance Level
  • MMI $39.25
  • FTRE $15.83
  • Average True Range (ATR)
  • MMI 1.15
  • FTRE 0.69
  • MACD
  • MMI 0.10
  • FTRE 0.08
  • Stochastic Oscillator
  • MMI 23.45
  • FTRE 25.85

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a leading national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: